Intuit Other Income (Expense) increased by 34.7% to $97.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 203.1%, from $32.00M to $97.00M. Over 4 years (FY 2021 to FY 2025), Other Income (Expense) shows an upward trend with a 16.8% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $14.00M | $8.00M | $50.00M | -$5.00M | -$1.00M | $8.00M | $5.00M | $23.00M | $22.00M | $46.00M | $22.00M | $42.00M | $27.00M | $71.00M | $2.00M | $38.00M | $32.00M | $86.00M | $85.00M | $72.00M | $97.00M |
| QoQ Change | — | -42.9% | +525.0% | -110.0% | +80.0% | +900.0% | -37.5% | +360.0% | -4.3% | +109.1% | -52.2% | +90.9% | -35.7% | +163.0% | -97.2% | >999% | -15.8% | +168.8% | -1.2% | -15.3% | +34.7% |
| YoY Change | — | — | — | — | -107.1% | +0.0% | -90.0% | +560.0% | >999% | +475.0% | +340.0% | +82.6% | +22.7% | +54.3% | -90.9% | -9.5% | +18.5% | +21.1% | >999% | +89.5% | +203.1% |